Article Details
Retrieved on: 2024-02-08 16:09:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vir Biotechnology, Inc. (NASDAQ:VIR - Free Report) - Research analysts at Leerink Partnrs decreased their FY2026 earnings per share (EPS) ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here